# Omega 3 Fatty Acid Treatment for Pediatric Musculoskeletal Health

> **NCT03127345** · PHASE2 · WITHDRAWN · sponsor: **Boston Children's Hospital**

## Conditions studied

- Esophageal Atresia

## Interventions

- **DRUG:** Omegaven
- **DRUG:** Intralipid

## Key facts

- **NCT ID:** NCT03127345
- **Lead sponsor:** Boston Children's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2019-09
- **Primary completion:** 2023-09
- **Final completion:** 2023-09
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Lack of funding
- **Last updated:** 2019-09-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03127345

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03127345, "Omega 3 Fatty Acid Treatment for Pediatric Musculoskeletal Health". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03127345. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*